According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$0.29 Million. a decrease over the revenue in the year 2023 that were of S$1.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | S$0.29 M | -73.06% |
2023 | S$1.09 M | -92.01% |
2022 | S$13.75 M | 473.4% |
2021 | S$2.39 M | -75.53% |
2020 | S$9.8 M | 76.86% |
2019 | S$5.54 M | -86.69% |
2018 | S$41.64 M | -26.26% |
2017 | S$56.46 M | 10.32% |
2016 | S$51.18 M | -10.81% |
2015 | S$57.39 M | 315.36% |
2014 | S$13.81 M | -19.02% |
2013 | S$17.06 M | 238.77% |
2012 | S$5.03 M | -60.3% |
2011 | S$12.68 M | 60.27% |
2010 | S$7.91 M | -38.18% |
2009 | S$12.8 M | 326.82% |
2008 | S$2.99 M | -56.64% |
2007 | S$6.91 M | 30.09% |
2006 | S$5.31 M | -41.58% |
2005 | S$9.1 M | 378.1% |
2004 | S$1.9 M | 1291.63% |
2003 | S$0.13 M | -58.39% |
2002 | S$0.32 M | |
2000 | S$9.64 M | -34.16% |
1999 | S$14.65 M |